REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Preparations Characterized By Special Physical Form > Food Or Edible As Carrier For Pharmaceutical Food Or Edible As Carrier For PharmaceuticalFood Or Edible As Carrier For Pharmaceutical patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/02/07 - 20070178140 - Compositions and methods for reducing food intake and controlling weight A formed food or other ingestible composition having at least one soluble anionic fiber and at least one multivalent cation wherein the combination of fiber and cation increases viscosity of digesta. Methods of reducing blood glucose levels or insulin levels are disclosed. Also disclosed are methods of controlling, ameliorating, or ... 07/26/07 - 20070172513 - Encapsulation of oxygen sensitive agents The present invention relates to the use of a mixture of modified starch and protein for encapsulating oxygen sensitive agents, wherein the modified starch is a starch derivative containing a hydrophobic group or both a hydrophobic and a hydrophilic group which has been further enzymatically hydrolyzed by an exo-enzyme. The ... 07/26/07 - 20070172512 - Methods of preventing peritonitis by administering lactic acid bacterium The present invention relates to the use of lactic acid bacteria capable of adhering to the mucosa of the intestine and especially colonizing it for the prevention of peritonitis. In particular, the present invention relates to the use of such lactic acid bacteria for the prevention of peritonitis caused by ... 07/26/07 - 20070172510 - Energy drink Disclosed are nutritional energy drinks and supplements. Also disclosed are methods of making nutritional drinks. The drinks provide energy to the body by refueling the body's fuel tank. The drinks comprise a core formula, to which additional ingredients are added to make a energy, performance or diet enhancing formula. The ... 07/19/07 - 20070166354 - Method of reducing the risk of retinopathy of prematurity in preterm infants Disclosed is a method of reducing the risk or severity of retinopathy of prematurity in preterm infants. The method comprises (a) measuring skin carotenoid levels in preterm infants, preferably by Raman Spectroscopy, and then (b) administering supplemental carotenoids to those infants in need thereof, wherein the supplemental carotenoids comprise lutein, ... 07/12/07 - 20070160650 - Composition and method to augment and sustain neurotransmitter production This invention describes a method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and ... 07/05/07 - 20070154526 - Ingestible carrier for medications and structure and method for making The present invention is an ingestible carrier for a medication to be taken orally by an individual. The carrier includes a cavity into which one or more medications can be inserted and frictionally retained by the carrier. The carrier is formed of an easily ingestible material and is shaped in ... 06/28/07 - 20070148210 - Composition for enhancing physical performance This invention relates to a composition that contains quercetin, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, caffeine, epigallocatechin gallate, epicatechin, epicatechin gallate, and epigallocatechin. ... 06/28/07 - 20070148209 - Allergic constitution ameliorator An agent for improving allergic predisposition is provided. This agent is effective in improving the allergic predisposition, safe, and readily ingestible. More specifically, an agent for improving allergic predisposition and an agent for suppressing production of IgE antibody containing a hydrolysate of water-soluble dietary fibers as its effective component are ... 06/21/07 - 20070141124 - Induced-viscosity nutritional emulsions Disclosed are induced viscosity nutritional emulsions comprising (A) protein having a protein-bound methionine sulfoxide content of 8% or less of the total protein-bound methionine, on a molar basis, (B) fat, and (C) an induced viscosity fiber system that provides the emulsion with a packaged viscosity of less than 300 cps ... 06/21/07 - 20070141123 - Emulsions comprising non-esterified phytosterols in the aqueous phase A stable emulsion in which an aqueous phase has one or more phytosterols or phytostanols, or mixtures thereof in free (non-esterified) form and an oil or fat phase has phytosterols or phytostanols, or mixtures thereof, in esterified form. ... 06/21/07 - 20070141122 - Nutritional composition and method of manufacture A nutritional composition, and method of making it, that includes a carbohydrate, an insulin potentiator, an amino acid, a muscle growth stimulator, an energy increaser and at least one flavoring ingredient. The composition may be provided in dry form for addition to a fluid or in liquid forms. The composition ... 06/21/07 - 20070141121 - Method of treating kidney disease The progression of kidney disease and especially polycystic kidney disease in humans may be retarded and the symptoms ameliorated by administration of an effective amount of soy molasses or isolated soyasaponins or mixtures thereof in conjunction with the essential amino acids. Restriction of protein to a moderate level of 0.8 ... 06/21/07 - 20070141120 - Peptide having an ace inhibiting effect Use of the tripeptide XPP, wherein X= C, M, S, T, or K, and/or salts thereof for the preparation of an angiotensin-converting enzyme inhibitor and food products comprising the tripeptide XPP. ... 06/21/07 - 20070141119 - Use of additionally fermented distillers grains for preventing and/or treating increased blood sugar values The present invention relates to the use of distillers grains fermented with a yogurt culture and/or buttermaking culture for producing a composition for preventing and/or treating increased blood sugar values. ... 06/14/07 - 20070134298 - Dietary supplement A dietary supplement comprises a combination of colostrinin and at least one of lactoferrin and selenium. ... 06/14/07 - 20070134297 - Device to aid in sexual pleasure There is provided a dissolving strip adapted to be placed on a person's tongue to aid in giving oral sexual pleasure to both men and women. The strip comprises: a dissolvable, orally consumable, composition; and the strip is flexible and adapted to adhere to a surface in the mouth, usually ... 06/07/07 - 20070128252 - Compositions and methods for treatment of body weight conditions A nutritional supplement composition having a therapeutically effective amount of peptides is provided for the treatment of body weight conditions. The nutritional supplement may also comprise milk minerals, such as calcium and/or be combined with a protein source including κ-casein fragment 106-169. The nutritional supplement composition is administered in amounts ... 06/07/07 - 20070128251 - Process for manufacturing chewable dosage forms for drug delivery and products thereof A palatable, soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the soft chews ... 05/31/07 - 20070122458 - Nicotine and chocolate compositions The present invention is drawn to nicotine-containing pharmaceutical compositions that comprise chocolate and method of using the compositions in different therapies, such as nicotine replacement therapy. ... 05/31/07 - 20070122457 - Nicotine and chocolate compositions The present invention is drawn to nicotine-containing pharmaceutical compositions that comprise chocolate and method of using the compositions in different therapies, such as nicotine replacement therapy. ... 05/31/07 - 20070122456 - Nicotine and cocoa powder compositions The present invention relates to a nicotine-containing pharmaceutical composition and methods of using the composition in therapies, such as nicotine replacement therapy. ... 05/31/07 - 20070122455 - Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions The present invention relates to water-soluble films incorporating anti-tacking agents and methods of their preparation. Anti-tacking agents may improve the flow characteristics of the compositions and thereby reduce the problem of film adhering to a user's mouth or to other units of film. In particular, the present invention relates to ... 05/31/07 - 20070122454 - Skin moisturizing agent for oral intake and functional foods and drinks The present invention provides functional food and beverage that produce a skin moisturizing effect through oral intake, that is excellently safe, and that may be taken regularly. The invention also provides a skin moisturizer for oral intake to be used in the functional food and beverage, as well as use ... 05/31/07 - 20070122453 - Moderating the effect of endotoxins The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of ... 05/31/07 - 20070122452 - Fat composition Provided is a composition permitting high systemic absorption of n-3 polyunsaturated fatty acids and high transfer of them to tissues and capable of fully exhibiting pharmacological effects which the fatty acids have. A fat composition containing one or more phospholipids having, as a constituent fatty acid, an n-3 polyunsaturated fatty ... 05/31/07 - 20070122451 - Biogically non-degradable peptides, angiostensin converting enzyme inhibitor, drug and functional food The present invention provides novel in vivo indigestible peptides that are highly absorbable and hardly digestible in living organism when administered orally or through other route, and expected to effectively exhibit functions, such as hypotensive effect, in living organism, and ACE inhibitors prepared with the peptides, and medicine or functional ... 05/10/07 - 20070104762 - Appetizer supplement to suppress age-related decline in capacity and appetite A method for administering daily micronutrient requirements (DMRs) comprising vitamins, minerals and essential fatty acids targeted to reduce appetite and/or the risks associated with aging. The DMRs are administered to individuals via food products. In an embodiment of the present invention, the DMRs are offered in the form of a ... 05/10/07 - 20070104761 - Low radiocarbon nucleotide and amino acid dietary supplements Methods for significantly lowering the carbon-14 content of DNA and histones in vertebrates, especially humans, to about 10% to about 98% below normal background levels and thereby reduce chromosomal damage using dietary supplements based on low radiocarbon nucleotides, amino acids, and other DNA and histone precursors. Administration of the supplements ... 05/10/07 - 20070104760 - Enteropathy ameliorating composition The present invention relates to a composition for preventing, ameliorating or treating a bowel disease, comprising galactomannan and/or arabinogalactan; a liquid food for preventing, ameliorating or treating a bowel disease, characterized in that the liquid food comprises a protein and galactomannan and/or arabinogalactan; and a composition for preventing, ameliorating or ... 05/03/07 - 20070098765 - Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof The present invention discloses methods of making a mixture of theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate, pharmaceutical compositions of the above mixture of theaflavins, diet supplement compositions of the above mixture of theaflavins and methods for using the above mixtures of theaflavin and pharmaceutical compositions thereof to treat or prevent ... 05/03/07 - 20070098764 - Colon cleansing compositions and methods A composition comprising, per litre of aqueous solution, from 30 to 350 g polyethylene glycol, from 3 to 20 g of an ascorbic acid component selected form the group consisting of ascorbic acid, a salt of ascorbic acid, or a mixture thereof, an alkali metal or alkaline earth metal sulphate, ... 05/03/07 - 20070098763 - Soluble fiber combinations for weight control and improving parameters of cardiovascular health A food or pharmaceutical agent is provided for treating or offsetting the risks of a disease or disorder such as a cardiovascular disease, a hypercholesterolemia disorder, a low serum high density lipid (HDL)/low density lipid (LDL) ratio, a hypertriglyceridemia disorder, and diabetes includes a pharmaceutical carrier, and a composition including ... 05/03/07 - 20070098762 - Immunemodulating oligosaccharides The present invention relates to a method for enhancing the immune system and the treatment and/or prevention of immune system related disorders in a mammal, particularly newborns, said method comprising the administration of acid oligosaccharide and neutral oligosaccharide. Food compositions suitable for use in the above method are also provided. ... 05/03/07 - 20070098761 - Processed fat composition for preventing/ameliorating lifestyle-related diseases The object of the invention is to provide a composition for prevention and/or amelioration of life-style related disease, and/or a composition for inhibition and/or amelioration of increase in body weight, comprising at least one compound selected from the group consisting of glabrene, glabridin, glabrol, 3′-hydroxy-4′-O-methylglabridin, 4′-O-methylglabridin and hyspaglabridin B as ... 04/26/07 - 20070092551 - Therapeutic agent A therapeutic agent and prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for an insulin-mimetic action, a food, beverage and feed, an agent for enhancing glucose uptake into a cell, and an agent for inducing differentiation into an adipocyte, characterized ... 04/19/07 - 20070087038 - Gelling compositions and methods A method for the administration of a composition that augments the acidity of gastric fluid such that intra-gastric gelation of the polysaccharide:acid soluble multivalent cation formulation is initiated independent of endogenous acid secretion. The composition includes:(a) at least one of a polysaccharide, modified polysaccharide, or polysaccharide salt, each capable of ... 04/19/07 - 20070087037 - Stimulation of cpt-1 as a means to reduce weight This invention provides methods and compositions for inducing weight loss and maintaining optimum weight comprising administering an agent that stimulates carnitine palmitoyl transferase-1 (CPT-1) activity to the patient in need, including human patients. These methods do not require inhibition of fatty acid synthesis. In particular, this invention provides methods for ... 04/19/07 - 20070087036 - Edible film for transmucosal delivery of nutritional supplements In one embodiment of the present invention a composition is provided comprising a film layer wherein the film layer rapidly dissolves in an oral cavity and a coating comprising a powder matrix, wherein the coating is applied to at least one side of the film layer and wherein the powder ... 04/19/07 - 20070087035 - Nutritional composition for wound healing A nutritional composition for promoting wound healing comprises a protein source, a lipid source and a carbohydrate source wherein no more than 1.8% of the total calories of the composition derive from arginine and wherein the protein source includes proline in an amount of at least 3% of the total ... 04/12/07 - 20070082030 - Fiber satiety compositions Ingestible compositions that include one or more anionic soluble fibers are provided herein. An ingestible composition can be in solid or liquid form. In certain cases, a solid ingestible composition includes an extruded food product, such as a crispy, that includes one or more anionic soluble fibers. Liquid ingestible compositions ... 04/12/07 - 20070082029 - Fiber satiety compositions Ingestible compositions that include one or more anionic soluble fibers are provided herein. An ingestible composition can be in solid or liquid form. In certain cases, a solid ingestible composition includes an extruded food product, such as a crispy, that includes one or more anionic soluble fibers. Liquid ingestible compositions ... 04/12/07 - 20070082028 - Compositions and methods for inducing satiety and reducing caloric intake Compositions and methods for inducing statiety and for reducing caloric intake having at least soluble anionic fiber and at least one soluble cation. The compositions may be solid, fluid, or mixtures thereof. ... 04/12/07 - 20070082027 - Compositions and methods for reducing food intake and controlling weight An ingestible composition to increase viscosity imparted to the digesta in an intestine that includes a soluble anionic fiber and a protected cation. The protected cation may be coated with an enteric coating, a lipid coating, or a sustained release coating. ... 04/12/07 - 20070082026 - Compositions and methods for reducing food intake and controlling weight A formed food or other ingestible composition having at least one soluble anionic fiber and at least one multivalent cation wherein the combination of fiber and cation increases viscosity of digesta. Methods of weight management including inducing satiety, reducing caloric intake, weight loss and improving weight loss, using the formed ... 04/12/07 - 20070082025 - Methods for achieving and maintaining weight loss Methods for achieving weight loss goals and maintaining weight loss including selecting an appropriate weight loss program and identifying a weight loss goal, followed by participating in the weight loss program until the weight loss goal is achieved; then ending the weight loss program participation; and consuming an ingestible composition ... 04/12/07 - 20070082024 - Tyrosinase activity inhibitor and ameliorant for facial blood flow A tyrosinase activity inhibitor and an ameliorant for facial blood flow that are excellent in terms of safety, and medicinal compositions, food compositions, and cosmetic preparations that contain the inhibitor and the ameliorant as active ingredients are provided. A tyrosinase activity inhibitor and an ameliorant for facial blood flow that ... 03/29/07 - 20070071794 - Drugs for treating diabetes The present invention provides an agent for recovering insulin secretion function which contains at least one of the amino acids selected from the group consisting of aspartic acid, cystine, serine, asparagine, isoleucine, histidine, hydroxyproline, glutamic acid, valine and salts thereof as an active ingredient; a functional food which contains the ... 03/29/07 - 20070071793 - Cure for prostate enlargement frequency of urination and cancer This is a chemical compound designed to eradicate cancer from the prostate (and possibly other parts of the body) restore the prostate to it's normal size, cure frequency of urination and restore urination back to it's youthful state. ... 03/22/07 - 20070065488 - Food composition having anti-stress action Food compositions which comprise, as an active ingredient, an extract of migratory fish or a mixture of nutritional components of a similar composition to the above-mentioned extract in an amount of 0.5 g or more per one meal of the extract or the mixture in terms of the solid content ... 03/22/07 - 20070065487 - Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof A colloidal crystalline solution comprising a xanthophyll ester having a high trans-lutein content and at least one oil is provided. The solution may be prepared by dissolving the xanthophyll ester in the oil. Methods of using the solution are also provided. ... 03/22/07 - 20070065486 - Migraine remedy The invention relates to uses and methods of treating migraine with a plant extract that includes a therapeutically effective dose of a mixture of flavonoids rich in proanthocyanidis. Methods and uses are described to substantially prevent migraine from occurring; reduce the frequency of migraine or reduce the severity of migraine ... 03/15/07 - 20070059341 - Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy The invention relates to the food and medical industries, medical cosmetics, dermatology, agriculture and the mixed feed industry. According to the invention vicinal dithioglycole (common formula RCH(SH)CH(SH)R−1 (I)) is used as a food additive, a food product, physiologically-active substances and active ingredients of forage additives and of forage, in cosmetic ... 03/15/07 - 20070059340 - Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same Disclosed are processes for stabilizing omega-3 fatty acids for use in food products. The processes permit creation of a variety of food forms and food ingredients that contain omega-3 fatty acids like docosahexaenoic acid and eicosapentaenoic acid wherein these foods and food forms are stable for months without developing fishy ... 03/15/07 - 20070059339 - 1-o-beta-d-glucopyranosylgeraniol-10,5-olide and use thereof A novel natural compound having various therapeutically effects is provided. The compound is obtainable from Sibiraea leaves by aqueous extraction and is represented by a formula (1) as follows. ... 03/08/07 - 20070053955 - Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain Compositions and methods for enhancing vascular integrity in animals are disclosed. The compositions and methods, which utilize long chain polyunsaturated fatty acids and nitric oxide releasing compounds are also effective for reducing ischemia-induced brain injury in an animal. ... 03/01/07 - 20070048354 - Synthetic nutritional formulations The present invention provides a synthetic nutritional formulation comprising a substantially pure free N-acetyl glucosamine in concentrations effective for enhancing organ development, enhancing an immune response, or increasing tissue repair or healing in a subject. A synthetic nutritional formulation of the invention may optionally comprise one or both of substantially ... 03/01/07 - 20070048353 - Production method of food and beverage products with high content of gamma-aminobutyric acid and food and beverage products with high content of gamma-aminobutyric acid A method for producing food and beverage products with a high content of γ-aminobutyric acid, wherein processed tomato products whose filtrate has a coloring degree between 0.02 and 0.2 when sugar content is adjusted to 3% are fermented with lactic acid bacteria, and food and beverage products with a high ... 02/22/07 - 20070042021 - Nutritional composition against side effects of chemotherapy of radiotherapy The present invention relates to a nutritional composition suitable for patients undergoing chemotherapy and/or radiation such as cancer patients. The composition, which may be in powder or liquid form, comprises casein and whey proteins, TGF-β and free glutamine. ... 02/22/07 - 20070042020 - Composition for the treatment of dysfunctional energy metabolism syndrome A nutritional composition for the treatment of syndromes related to dysfunctional energy metabolism is provided. The composition comprises a combination of L-carnitine, acetyl-L-carnitine, pantothenate and niacinamide. Methods of treatment of dysfunctional energy metabolism are also disclosed. ... 02/22/07 - 20070042019 - Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein The invention relates to a method for the treatment and/or prevention of chronic wounds, said method comprising enterally administering to a patient a composition wherein protein represents between 10 and 40% of the total caloric content of the composition; carbohydrate represents between 15 and 90% of the total caloric content ... 02/15/07 - 20070036837 - Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares and other animals A novel dietary supplement and methods for the manufacture and administration of the same are disclosed for feeding to equine mares and other animals prior to parturition to boost the colostrum immunoglobulin level in lactating equine mares and other animals and thereby enhance the passive transfer of immunity to neonatal ... 02/15/07 - 20070036836 - Amino acid supplementation for a healthy microbiota ecosystem The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of ... 02/08/07 - 20070031476 - Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its use in the preparation of an agent useful for the treatment and prophylaxis of cancer. The invention also relates to a method ... 02/08/07 - 20070031475 - Nutritional composition with unsaturated fatty acids and trace elements The present invention relates to a powdered nutritional composition, which comprises at least long-chain polyunsaturated fatty acids and trace elements, such as iron, besides optional further constituents, such as macro- and micronutrients. Due to encapsulation of the iron source with or in a fat, wax or mixtures thereof, lipid-oxidation may ... 02/01/07 - 20070026050 - Method for production of arachidonic acid The present invention relates to a process for producing arachidonic acid. In one embodiment, Mortierella sect. schmuckeri microorganisms are cultured in fermentation medium, preferably containing a component of a complex nitrogen source. Further disclosed is a food product which includes Mortierella sect. schmuckeri microorganisms or lipid isolated from such microorganisms ... 02/01/07 - 20070026049 - Method of increasing lean body mass and reducing body fat mass in infants Disclosed is a method of increasing lean body mass and reducing fat body mass in infants, said method comprising administration to an infant, term or preterm, a nutritional formula comprising a source of DHA and ARA. It has been found that the administration of DHA and ARA, or a source ... 01/25/07 - 20070020313 - Composition of amylase inhibitors and fibers to reduce the absorption of starch in human digestion from starchy foods, and to reduce the glycemic index of starchy foods A composition of amylase inhibitors and fibers to reduce the absorption of starch in human digestion from starch-containing foods, and to reduce the glycemic index of starch containing foods. ... 01/11/07 - 20070009576 - Nutritionally fortified liquid composition with added value delivery systems/elements/additives A shelf-stable, ready to use, water-like composition for humans/animals; as an adjunct to fiber-water, and/or safe drinking water, consumed directly, tube feedings, or in the preparation/reconstitution of food(s)/beverage(s). Fortified Fiber-Water is fiber-water, with added delivery systems: Encapsulations/particles, of different size(s), shape(s), material(s), colors, non-visible, serving one or more functions: improved ... 01/11/07 - 20070009575 - Novel use of antisecretory factor The present invention relates to the use of an antisecretory protein or homologues thereof having the same properties, or certain fragments thereof in the manufacture of a medicament or a medical food for inducing improved rescue of injured or diseased nervous tissue, proliferation, apoptosis, differentiation and/or migration of an embryonic ... 01/11/07 - 20070009574 - Food product providing sustained blood levels of exogenous substances The present invention relates to a food product comprising soluble fibre and at least one exogenous biologically active substance. It further relates to the uses of a mixture comprising at least soluble fibre and at least one exogenous substance in the preparation of a food product to avoid short-term peaks ... 01/04/07 - 20070003601 - Quick water-dissolving edible anti-hunger film containing fibres that swell in the presence of water An edible anti-hunger film partially quick-dissolving in water and in mouth saliva, comprising a starch, a highly water-soluble cellulose and insoluble natural food fibres which swell on contact with water, with saliva and with gastric juices to form semisolid particles which swell within the oral cavity and in the stomach ... 01/04/07 - 20070003600 - Methods for reducing c-reactive protein The present disclosure is directed to a method for reducing the level of c-reactive protein comprising administering to a subject in need thereof a c-reactive protein level reducing amount of at least one phytosterol. ... 12/28/06 - 20060292204 - Flavanone compound and uses thereof Alternatively, each of an antioxidant, an antimicrobial agent, an antitumor agent, a food and beverage product, cosmetics, a quasi-drug and a pharmaceutical of the present invention contains at least one flavanone compound selected from the group consisting of nymphaeol-A, nymphaeol-B, and nymphaeol-C. ... 12/21/06 - 20060286150 - Therapeutic methods and compositions involving isoflavones Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R1 is H, or RACO where RA is C1-10alkyl or an amino acid, R2 is H, OH, or ORB where RB is an amino acid, or CORA ... 12/21/06 - 20060286149 - Low molecular weight polyglucosamines and polygalactosamines Compositions containing enriched populations of beta linked low molecular weight polymers of galactosamine and glucosamine are provided. The compositions are useful, for example, as antibacterial additives for food and other edible applications, as precursors for synthesizing other biologically active molecules related to chitin/chitosan oligomers, and/or as pharmaceutical compounds. ... 12/14/06 - 20060280779 - Phosphatidylserine enriched milk fractions for the formulation of functional foods Disclosed is a bovine milk derived phosphatidylserine source of natural composition having excellent dispersibility and organoleptic as well as physical stability. The source is usefull in neutraceutical in powder, liquid or dispersion form. The source can be prepared from serum from butter oil production or from the retentate from microfiltration ... 12/14/06 - 20060280778 - Homeopathic teething pain relief composition and method A composition for the relief of symptoms of teething in human children, and a method of its use, is disclosed. The composition includes effective amounts of the homeopathic ingredients Belladonna 3C, Chamomilla 3C and Coffea Cruda 3C, preferably combined with distilled water to form a solution. The solution is introduced ... 12/14/06 - 20060280777 - Encapsulated energy gel compositions Encapsulated energy gel compositions are provided. The compositions include an energy gel center contained within an edible coating. ... 12/14/06 - 20060280776 - Diet food The diet food of this invention having effects to reduce body weight and prevent/improve obesity and atherosclerotic or metabolic disorders includes an ω-3 PUFA or an ω-6 PUFA, and at least one of L-arginine, L-ornithine, an L-arginine precursor and an L-ornithine precursor, and further includes diacylglycerol, a middle or short ... 12/07/06 - 20060275346 - Liquid seasoning A liquid seasoning, comprising: (A) 3.55% by weight or less of sodium; (B) 0.5 to 4.2% by weight of potassium; and (C) 0.05 to 20% by weight of a substance having an antihypertensive effect. Salty taste is sufficiently provided despite its low sodium concentration, and pharmacological functions such as an ... 12/07/06 - 20060275345 - Collagen hydrolysate The use of collagen hydrolysate as dietary supplement to baby food, particularly to improve the general state of health in infants and bring about a reduction in restlessness, vomiting after food intake and flatulence, is disclosed. ... 12/07/06 - 20060275344 - Flavoring of drug-containing chewing gums A chewing gum comprising at least one active pharmaceutical ingredient (API) with a core onto which is applied at least one inner polymer film coating and thereafter onto which is applied at least one outer hard coating. A preferred API is nicotine. Flavoring agents may be incorporated in the core, ... 11/23/06 - 20060263411 - Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions and certain subgenera or species thereof, as flavor or taste modifiers, particularly, savory (“umami”) taste modifiers, savory flavoring agents and savory flavor enhancers in foods, beverages, and other comestible compositions. ... 11/23/06 - 20060263410 - Biological method for detoxication of a liquid food medium The ivention concerns a biological method for decontaminating mycotoxins present in a liquid food product by adsorbing them onto insoluble vegetable fibers, and a brewing method comprising at least one decontamination step according to said method, as well as food products at least partly detoxified obtained by implementing said method. ... 11/16/06 - 20060257454 - Conjugated fatty acid esters A conjugated fatty acid glyceride, which is formed by converting conjugated fatty acids having conjugated double bond(s) in the molecule into glycerol esters, to more effectively exert the inherent physiological effects of the conjugated fatty acids and control the bitterness or astringency of the conjugated fatty acids, thereby making the ... 11/16/06 - 20060257453 - Powderous formulations of fat-soluble active ingredients Suitable powderous formulations containing a fat-soluble active ingredient, e.g., vitamin A, in a matrix of a native lupin protein composition are disclosed. ... 11/09/06 - 20060251703 - Composition comprising an edible acid or its acidic salt and the use thereof This invention relates to a drug containing edible acid and/or acidic salt as active agent to treat and alleviate hypersensitivity diseases by lowering the humor pH and method; to improve individual hypersensitivity diseases by uses of health care food, which are made from said edible acid and/or acidic salt, or ... 11/02/06 - 20060246115 - Nutritional products for ameliorating symptoms of rheumatoid arthritis Disclosed are nutritional compositions for treating rheumatic diseases. The nutritional compositions contain a fat source containing at least one of: 1) at least one omega-3 long chain polyunsaturated fatty acid and 2) at least one omega-6 long chain polyunsaturated fatty acid; a carbohydrate source; a protein source; and at least ... 11/02/06 - 20060246114 - Multiple component food product useful for delivering glucosamine and/or nacetyl-d-glucosamine Food products containing at least two components are provided. These products have at least one baked component and at least one non-baked component. The non-baked component contains either GLCN and/or NAG. ... 10/26/06 - 20060240076 - Preparation and use of hydrogels The present invention pertains to a method for preparing a hydrogel in dry conditions that contains high loading of the active ingredient, preferably flavor or fragrance molecules. The hydrogel compositions are initially in solid form and preferably extruded and sized to form the desired shape and size. The actual hydrogel ... 10/26/06 - 20060240075 - Carnitine retention A composition for influencing carnitine retention in biological tissue is disclosed. The composition comprises a carnitine substance and an agent to increase sodium potassium ATPase pump activity in the tissue, and/or to increase the activity of a carnitine transport protein, and/or increase blood/plasma insulin concentration. ... 10/26/06 - 20060240074 - Novel triple mineral salts of (-)-hydroxycitric acid and processes for preparing the same This invention also includes a process for preparing the triple salts by adding stiochiometric amounts of aqueous solutions of the compounds of the desired metal to an aqueous solution of (−)-HCA. Preferably an extract from garcinia fruit ring is used as a starting material. Compounds of this invention are substantially ... 10/19/06 - 20060233863 - Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy Described herein are various lipid mixtures, more particularly special mixtures of fatty acids esters, which may be phytosterol esters and/or glyceride esters. Said mixtures are evaluated in the context of their ability to, upon consumption, affect the levels of circulating LDL and HDL particles, and their therapeutic effect on conditions ... 10/19/06 - 20060233862 - Process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof A method for preparing a fat composition by reacting a sterol raw material with a triglyceride raw material to create the fat composition. ... 10/19/06 - 20060233861 - Modulation of atp production or content in the hypothalamus A method for the identification of agents for use in the treatment of metabolic diseases, disorders or conditions, for example obesity and diabetes, or for causing weight loss without substantial adverse health effects, in an animal in need of such treatment, comprises the step of identifying an agent that modulates ... 10/12/06 - 20060228397 - Dietary supplement, and methods of use One aspect of the invention provides dietary fiber compositions comprising effective amounts of glucomannan, xanthan gum, and alginate to produce a desired viscosity. The invention also provides food products comprising an effective amount of a dietary fiber composition. In other aspects, the invention provides methods for preparing a dietary fiber ... 10/12/06 - 20060228396 - Arginine-containing compositions and methods for increasing blood flow using same A composition for increasing blood flow is provided, wherein side effects such as lowering of blood pressure are reduced and blood flow is effectively increased in the capillaries. A composition containing arginine in an amount from 25 mg/kg body weight to 150 mg/kg body weight is also provided. A food ... 10/12/06 - 20060228395 - Vitamin e phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage Compositions containing liposomes may be prepared by sonicating the liposomes in a clear liquid to obtain a clear composition of matter. Beverages prepared are clear and visually appealing. Compositions of the invention help to protect from cell damage. ... 10/05/06 - 20060222682 - Nutraceutical moringa composition The present invention incorporates portions from the Moringa plant into a nutraceutical beverage to provide a therapeutic effect in a person. The leaves, seeds, and fruit of the Moringa plant are used in the present invention to provide a biologically metabolized nutritional composition for health, well-being, and for treatment of ... 09/28/06 - 20060216330 - Peptides having an ace inhibiting effect Use of the pentapeptide IIAEK, the pentapeptide IPAVF and/or the hexapeptide IPAVFK and salts thereof for the preparation of an angiotensin-converting enzyme inhibitor. ... 09/21/06 - 20060210610 - Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use are disclosed. ... 09/21/06 - 20060210609 - Fucoidan compositions and methods for dietary and nutritional supplements Compositions and methods relating to partially hydrolyzed fucoidan for use in dietary supplements are described. Fucoidan from brown seaweeds is partially hydrolyzed and then mixed with other ingredients for use as a dietary supplement in beverage, capsule, or tablet form. The fucoidan is partially hydrolyzed with acid and heat. The ... 09/21/06 - 20060210608 - Mineral composition The present invention relates to a mineral composition, characterized in that the mineral composition comprises 100 parts by weight of a metal salt having a solubility product in water at 25° C. of 1.0×10−7 or less and 0.5 to 50 parts by weight of an emulsifier having an HLB of ... 09/21/06 - 20060210607 - Water-soluble isoflavone composition, process for producing the same, and use thereof An isoflavone composition which contains an α-glucosyl isoflavone and isoflavone and optionally an isoflavone aglycone, wherein the ratio of the amount of aglycone in the isoflavone and the isoflavone aglycone in total to the amount of aglycone in the α-glucosyl isoflavone [(the amount of aglycone in α-glucosyl isoflavone)/(the amount of ... 09/21/06 - 20060210606 - Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood The present invention aims at preventing or retarding a transition to hemodialysis treatment in kidney failure or decreasing the number of implementation of the hemodialysis therapy and preventing or lessening occurrence of accompanying hyperammonemia in hepatic insufficiency. To accomplish the purposes described above, the pathological improvement food of the invention ... 09/14/06 - 20060204551 - Synergistic salivation agents Provides is a salivation cocktail that comprises a food acid and a tingling sensate. The combination of a food acid and a tingling sensate has been found to synergistically increase salivation. ... 09/14/06 - 20060204550 - Food and beverages containing l-carnitine derivatives The present invention relates to foods and/or. beverages containing L-carnitine derivatives that can be used to supplement L-carnitine deficiencies and/or preserve one or more properties of the foods and/or beverages. ... 09/14/06 - 20060204549 - Method of improving nutrient utilisation by a mammal and a composition for use therein The invention relates to a method of stimulating nutrient utilization, especially through improved gastric emptying, comprising oral administration of a nutritional composition. The invention is concerned with a method of improving nutrient utilization by a mammal comprising orally administering a lactoferrin-containing nutritional composition to the mammal in an amount effective ... 09/07/06 - 20060198872 - Plant based dietary supplement for improving the duration and quality of sleep The present invention relates to compositions for treating insomnia or sleeplessness. The compositions of the present invention comprise jujube extract and at least one of white peony extract, radix polygala extract, and passion flower extract. The extracts used in the compositions of the present invention bind strongly to GABA receptors ... 08/31/06 - 20060193896 - Process for manufacturing a delivery system for active components as part of an edible composition A method of manufacturing a delivery system of at least one active component encapsulated in an encapsulating material, which is useful, for example, for providing delayed and/or controlled release of the active is described. ... 08/31/06 - 20060193895 - Additive for food and beverage, pharmaceutical composition, glut4 translocator, and method for translocating glut4 wherein R1 to R4 are each a glycoside group, a hydroxyl group, or a hydrogen atom, R5 is a carboxyl group and R6 to R8 are each a methyl group or a hydrogen atom. ... 08/24/06 - 20060188548 - Satiety promoting beverage and use in a diet to moderate food consumption A satiety promoting beverage and a weight control regimen using it are described comprising: fiber, protein, sweetener and preferably calcium and a catechin, such as purified epigallocatechin gallate derived from green tea. The ingredients are employed in amounts sufficient that a single serving provides a feeling of satiety, both initially ... 08/17/06 - 20060182784 - Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis The invention relates to a terapeutical composition comprising a protein hydrolysate and a plant sterol, wherein the weight ratio of the plant sterol to the protein hydrolysate is from 1:0.02 to 1:150. The invention also relates to a terapeutical composition comprising a protein hydrolysate and a synthetic emulsifier and/or a ... 08/10/06 - 20060177485 - Animal feed composition for increased production of glutathione peroxidase and superoxide dismutase A food composition for consumption by mammals is designed to increase the production of glutathione peroxidase and superoxide dismutase. A serving of the food composition has a total weight and includes, in order of decreasing weight, a meat, a brassica vegetable, and brown rice. ... 08/10/06 - 20060177484 - Cheese alternative product and process for preparing a cheese alternative product A cheese alternative product is prepared from filled milk formed from dairy origin skimmed milk and vegetable oil. The vegetable contains blood cholesterol lowering agent in an amount such that in the product the blood cholesterol lowering agent has a blood cholesterol level lowering effect. The blood cholesterol lowering agent ... 08/03/06 - 20060171993 - Method of improving antioxidant status of an infant The present invention relates generally to a method of improving the antioxidant status of an infant. More particularly, the present invention relates to a method of improving the antioxidant status of an infant by administering a mixture of natural tocopherols. The natural tocopherol mixture is an effective blend of α- ... 08/03/06 - 20060171992 - Blood glucose regulating composition The invention provides the use of a whey protein hydrolysate in an edible composition the whey protein hydrolysate being able to induce the cellular release of glucagon-like-peptides and cholecystokinins and/or increasing glucose uptake in target tissues, wherein the whey protein hydrolysate regulates blood glucose levels or results in, or is ... 07/27/06 - 20060165758 - Polymer controlled induced viscosity fiber system and uses thereof The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced viscosity fiber system and the liquid products that incorporate the induced viscosity fiber system. Further, the invention relates to ... 07/27/06 - 20060165757 - 5-hydroxysapogenin derivatives with anti-dementia activity The invention discloses the use of 5-hydroxysapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical composition are also disclosed. ... 07/27/06 - 20060165756 - Method for weight management The present invention is directed to a method for managing body weight by measuring preload efficiency and having the energy load of a food serving and providing information as to the measured preload efficiency and energy load of the selected food serving to enable an informed choice of an appropriate ... 07/20/06 - 20060159726 - Method and compositions for potentiating pharmaceuticals with amino acid based medical foods The methods and compositions for potentiating pharmaceuticals with amino acid based medical foods provides improved cognitive function; induced and maintained sleep; reduced pain, inflammation, blood pressure, anxiety, asthma, duration of viral infection, insulin resistance, and appetite; and treated depression. The amino acid based medical foods, co-packed with at least one ... 07/20/06 - 20060159725 - Herbal compositions A composition containing extracts obtained form Fructus Crataegi, Semen Zizyphus, Fructus Schizandrae, and Panax Ginseng. Also disclosed is a method of treating cancer or modulating an immune response in a subject and a method of inducing a cytokine in a cell with the composition. ... 07/20/06 - 20060159724 - Nutritional supplement for the management of weight Described herein is a low-glycemic nutritional supplement to be incorporated into the diet of an overweight or obese patient comprising low glycemic index ingredients including carbohydrate source, a source of protein, and a source of fat, and further comprising a source of green tea extract, a source of 5-hydroxytryptophan (5-HTP), ... 07/13/06 - 20060153899 - Palatinose for enhancing dietary supplement and pharmaceutical delivery The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of ... 07/13/06 - 20060153898 - Nocturnal muscle enhancing composition and method A method and nutrient supplement composition for nocturnal administration to human subjects where the nutrient supplement composition includes both a sustained timed release portion and a rapid release portion, both portions containing a mixture of edible food proteins and edible amino acid building blocks with a portion of these key ... 07/13/06 - 20060153897 - Zinc-containing foods It is intended to provide foods such as health (supplementary) foods, nutrition (supplementary) foods and foods with health claims (foods for specified health uses and foods with nutrient function claims) containing zinc compositions which are less toxic and have a high insulin-like activity. Foods containing organic compounds capable of forming ... 07/06/06 - 20060147497 - Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof An administration form for oral administration of active substances, vitamins and/or nutrients including a drinking straw (1) provided with a barrier device (3) which is impermeable to the active substance formulation, vitamin formulation and/or nutrient formulation (2) and which is permeable to air and to a transport liquid. The closing ... 07/06/06 - 20060147496 - Methods of diagnosing small intestinal bacterial overgrowth (sibo) and sibo-related conditions Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune ... 07/06/06 - 20060147495 - Amino acid-based nutritional formulation A ready to feed nutritional formulation for consumption by persons with an inborn error of metabolism, the formulation comprising: a homogenised blend water, calcium and amino acid moieties in a profile appropriate to the inborn error, said amino acid moieties being selected from the group consisting of free amino acids, ... 07/06/06 - 20060147494 - Bioactive compounds protection method and compositions containing the same The present invention relates to means for protecting bioactive materials in mammalian food or feed formulations used to enhance the health status of mammals ... 07/06/06 - 20060147493 - Packaging and dispensing of rapid dissolve dosage form An oral dosage delivery vehicle comprising an edible film including a uniformly distributed active ingredient, wherein said film comprises dosage units releasably joined by one or more weakened sections, which permit said dosage units to be detached from said film. ... 06/29/06 - 20060141007 - Agent with a retarded release of substances The present invention relates to a composition for producing a satiation effect and for weight reduction comprising at least one compound which is swellable and comprises nutrients. ... 06/22/06 - 20060134180 - Encapsulated polyunsaturated fatty acids The present invention relates to process for the preparation of particles comprising an oil comprising polyunsaturated fatty acids (PUFA), to particles susceptible to be obtained by the process and to a method for increasing stability of PUFAs in oils at temperatures above 70° C. The process involves the step of ... 06/22/06 - 20060134179 - Health food product The present invention provides a health food product comprising (A) proanthocyanidins, (B) ascorbic acid or a derivative thereof, and (C) L-cysteine or a derivative thereof. Preferably, proanthocyanidins containing at least 20 wt % of OPCs are used. The health food product of the present invention makes the body itself healthy ... 06/22/06 - 20060134178 - Composition containing organic substance having double bond with improved oxidative stability To an organic substance having a double bond such as a polyunsaturated fatty acid was added an antioxidative component containing an antioxidative sesame component and ascorbic acid or an ascorbyl fatty acid ester. The above method provides a composition containing an organic substance having a double bond exhibiting enhanced oxidative ... 06/15/06 - 20060127450 - Composition containing higher fatty acid derivative and foods and drinks An object of the invention is to provide a composition containing a higher fatty acid derivative, which can be easily produced at low cost, is effective as an agent for prevention and treatment of osteoporosis induced by various factors such as diet, dietary restriction, etc., is highly safe, and can ... 06/15/06 - 20060127449 - Method and composition for lowering cholesterol Compositions and methods are provided for using natural waxes or wax sub-fractions to maintain healthy blood lipid profiles, illustratively by lowering total cholesterol, lowering LDL-cholesterol, raising HDL cholesterol, and/or lowering triglyceride levels. Compositions and methods are also provided to treat symptoms of metabolic syndrome, including weight gain. ... 06/15/06 - 20060127448 - Use of low-glycemic sweeteners in food and beverage compositions There is described a process for preparing a food or beverage composition having sweetness and a low glycemic index that entails incorporating in the composition a low glycemic index product comprising sucrose and an acceptor selected from the group consisting of a sugar and a sugar alcohol having free hydroxyl ... 06/15/06 - 20060127447 - Poly-gamma-glutamate having ultra high molecular weight and method for using the same The present invention relates to a poly-gamma-glutamate (PGA) having an ultra-high molecular weight greater than 5,000 kDa. The ultra-high molecular weight PGA according to the present invention has a mean molecular weight greater than 13,000 kDa, and more than 95% of its molecules have a molecular weight ranging from 3,000 ... 06/01/06 - 20060115518 - Liquid seasoning The present invention provides a liquid seasoning, which brings on a sufficient salty taste although it has a low common salt concentration, and which exhibits for example a pharmacological effect such as an antihypertensive effect at a high level. The present invention relates to a liquid seasoning, which contains the ... 06/01/06 - 20060115517 - Liquid seasoning The present invention provides a liquid seasoning, which brings on a sufficient salty taste although it has a low sodium concentration, and which exhibits for example a pharmacological effect such as an antihypertensive effect at a high level. The present invention relates to a liquid seasoning, which contains the following ... 05/18/06 - 20060105023 - Treatment of neurological disorders with nicotine Neurological disorders, such as migraine and addiction to smoking tobacco, are treated by the administration of an effective amount of nicotine, preferably in a water solution of nicotine processed to diminish the odor, taste, and smell of nicotine. ... 05/18/06 - 20060105022 - Process for preparing crosslinked hyaluronic acid gel [PROBLEMS] A novel process which can simply prepare a crosslinked hyaluronic acid gel having a small crosslinking agent content and exhibiting excellent viscoelasticity is provided. [MEANS TO SOLVE] A method of producing cross-linking hyaluronic acid gel, comprising stirring and mixing a mixture containing 20 W/V % or more of hyaluronic ... 05/18/06 - 20060105021 - Cholesterol-reducing liquid A dry-blended cholesterol-reducing composition and its method of manufacture are disclosed herein, wherein such cholesterol-reducing composition is formed by adding a dry-blended mixture including cholesterol-lowering active ingredients to a liquid, wherein the dry-blended mixture evenly disperses in the liquid for human consumption. The cholesterol-lowering active ingredients include phytosterols, inositol, policosanol, ... 05/18/06 - 20060105020 - Highly absorbable taste and odor free organic nutritional supplement made from food by products and mixable with solids and liquids, and method of making such The process includes a mix of cheese production whey (residual liquid from cheese manufacture) with blood of slaughter animals, whereby a biological process is undertaken with whole whey and through a thermal process proteins are precipitated and the yeast cells of the biomass are inactivated, both of which are separated ... 05/04/06 - 20060093651 - Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials This invention relates to drinks and foods having osteogenetic function, each of which comprises as an active ingredient an effective amount of a culture of a propionic acid bacterium and/or a lactic acid bacterium, said culture containing 2-amino-3-carboxy-1,4-naphthoquinone; and preventives and/or remedies for metabolic bone diseases, each of which comprises ... 05/04/06 - 20060093650 - Methods for regulating weight and size of animals The invention provides methods and compositions for regulating weight and size in animals. ... 05/04/06 - 20060093649 - Food composition for recovery from fatigue In the present application are disclosed a food composition for recovery from fatigue, comprising, as an effective ingredient, an extract of migratory fish such as a Perciformes Scombrina, or a composition of the make-up similar to the extract, according to which food composition can be provided a food composition for ... 04/27/06 - 20060088575 - Homeopathic preparations of purified growth factors and purified growth hormones and associated carriers A preparation comprising a homeopathic potency of a purified composition, such as insulin-like growth factor, insulin-like growth factor-1 (IGF-1), growth hormone, transforming growth factor (TGF), TGFβ1, fibroblast growth factor (FGF), FGF1, FGF2, GM-CSF, M-CSF, PDGFββ, nerve growth factor (NGF) and epidermal growth factor (EGF), is provided. The concentration of the ... 04/27/06 - 20060088574 - Nutritional supplements The invention provides nutritional supplements for an oral or enteral administration to humans, whether in satisfactory health, or having a medical condition. These supplements can provide humans with a complete, balanced nutrition in a bioavailable form, either as a food supplement or as a meal replacement, and preferably includes one ... 04/27/06 - 20060088573 - Composition having action preventing or alleviating symtoms or diseases due to aging of blood vessels A composition and food or beverage containing arachidonic acid or a compound having arachidonic acid as a component fatty acid and having an action preventing or alleviating symptoms or diseases due to aging of the blood vessels. ... 04/13/06 - 20060078596 - Treatment of muscle fatigue The present invention involves the use of a compound that reduces the level of free fatty acids circulating in the plasma of a subject in the manufacture of a medicament for the treatment of prevention of muscle (particularly cardiac or skeletal muscle) impairment or fatigue. ... 04/13/06 - 20060078595 - Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall A method for treatment for deterioration of a mucosal barrier, an intestinal dysfunction or injury, suboptimal intestinal wall maturation of new-borns, undernutrition, suboptimal intestinal blood flow, allergy, sepsis, translocation of pathogenic bacteria through an intestinal wall, endotoxaemia, or viral diarrhoea, in which the method includes orally or enterally administering to ... 04/13/06 - 20060078594 - Iron complex This invention relates to certain iron complexes which comprise ferrous or ferric iron and mono-, bi, tri- or hexadentate ligands containing a five- or six-membered aromatic or heterocyclic ring for use in the treatment and/or prevention of nutritional disorders and compositions containing such iron complexes. The iron complexes enhance the ... 04/13/06 - 20060078593 - Nutritional compostions comprising a soluble viscous fiber in a solid crisp matrix Disclosed are nutritional compositions having a solid crisp matrix, or a flour derived from the solid crisp matrix, said matrix comprising (A) from about 10% to about 50% by weight of a soluble viscous fiber, preferably guar; (B) from about 10% to about 99% by weight of a carbohydrate other ... 04/06/06 - 20060073188 - Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same The invention relates to novel fast-disintegrating, or even instant-disintegrating, homogeneous microporous compositions for pharmaceutical, veterinary, food, dietetic or cosmetic use, intended for the oral route or to be applied in contact with the mucous membranes and a method for producing them. ... 04/06/06 - 20060073187 - Use of arachidonic acid for normalization of infradian rhythm A composition having a normalizing action for infradian rhythm and/or a synchronization promoting action for circadian rhythm (biological clock) containing arachidonic acid and/or an arachidonic acid-containing compound. ... 04/06/06 - 20060073186 - Nutritional compositions The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate ... 03/30/06 - 20060067988 - Pharmaceutical formulations designed to supplement the diet of anorexic patients The present invention relates formulations designed to supplement the diet of patients who are anorexic, otherwise debilitated or convalescent, or suffer from other eating disorders, comprising casein hydrolysates and proteins derived from whey in the ratio of 1:1 and 1:5 in weight respectively. ... 03/30/06 - 20060067987 - Composition, a food, and a beverage having an anti-obesity action Compositions, foods, and beverages which contain a salt-free or a reduced-salt fermented soybean paste-like food material in which the salt content is 5% or less, obtained by hydrolyzing soybean by a koji mold have an excellent anti-obesity action. ... 03/30/06 - 20060067986 - Compositions and methods for treatment of body weight conditions A nutritional supplement composition having therapeutically effective amounts of milk minerals including calcium, a protein source including kappa-casein fragment 106-169, and enzyme-inhibiting peptides is provided for the treatment of body weight conditions. The nutritional supplement composition is administered in amounts effective for limiting weight gain and/or enhancing weight loss, as ... 03/30/06 - 20060067985 - Hypoallergenic composition This invention is directed generally to compositions (including foods, supplements, treats, toys, etc.) for animal (including pet) consumption, and particularly hypoallergenic compositions, and more particularly semi-solid hypoallergenic compositions and hypoallergenic compositions that comprise a hydrolysate. This invention also is directed generally to methods for using such compositions. This invention is ... 03/23/06 - 20060062827 - Nutritional supplement composition and method A nutritional supplement composition containing a mixture of whey protein, amino acids, and other beneficial constituents, and a method for making the composition in a nutritionally compact, easy-to-use form. The composition is made by processing a mixture of whey protein, amino acids, minerals, vitamins, and other selected ingredients at an ... 03/16/06 - 20060057188 - Dietary supplement energy-providing to skeletal muscles Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q10, nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines. ... 03/16/06 - 20060057187 - Emulsions containing unsaturated fatty acids and esters thereof The disclosed invention relates to emulsions containing, based on the total weight of the emulsion, a) 0.1 to 50% by weight of a conjugated linoleic acid or derivative thereof, b) 0.1 to 30% by weight of a vegetable lecithin mixture, c) 0 to 20% by weight of a co-emulsifier, d) ... 03/16/06 - 20060057186 - Oral contraceptive multivitamin compound and methods of administration A pharmaceutical preparation comprising progestin, estrogen and a multivitamin agent. The progestin may be between 0 and 0.50 mg Desogesterel and the estrogen may be between 0 and 0.2 mg Ethinyl Estradiol. The multivitamin agent may be any combination of alpha carotene, beta carotene, biotin, bioflavonoid, calcium, chasteberry fruit, chromium, ... 03/16/06 - 20060057185 - Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person Arachidonic acid and/or compounds containing arachidonic acid as a constituent fatty acid are used to obtain compounds which prevent decline of, improve or enhance normal responses of cognitive abilities of a healthy person, and which are highly suitable for pharmaceuticals as well as food products, with minimal side effects. ... 03/09/06 - 20060051399 - Remedies for liver diseases, hyperlipemia and diabetes Drugs and foods for preventing and/or treating liver diseases, hyperlipemia and/or diabetes containing a peptide which is composed of L-amino acids constituting natural proteins, has an L-glutamine content of from 15 to 60% by mass and has an average molecular weight of from 200 to 100,000; and foods containing this ... 03/02/06 - 20060045906 - Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle A method for activating the protein synthesis machinery and deactivating catabolic processes within skeletal muscle by regulating molecular signals to control anabolic and anti-catabolic activity in skeletal muscle via nutrients including but not limited to amino acids and growth factors. Also provided is a supplemental dietary composition that may include ... 03/02/06 - 20060045905 - Composition for repressing transformation growth factor beta A composition for repressing transformation growth factor β contains theanine as an active substance. The composition is useful for preventing or treating chronic glomerulonephritis, renal interstitial fibrosis, hepatic fibrosis, hepatic cirrhosis, idiopathic interstitial pneumonia, keloid, hidebound disease, arterial sclerosis, myocardial infarction, cardiac fibrosis, restenosis, acute megakaryoblastic leukemia, adult T-cell leukemia, ... 02/23/06 - 20060039954 - Ocular formulations with neuroprotectants to reduce alzheimer and neurotoxic risks created by large zinc dosages Formulations marketed to elderly consumers for preventing or treating age-related eye diseases such as macular degeneration are modified in various four ways, compared to the formulations tested in the first “Age-Related Eye Disease Study” (AREDS-1) clinical trial. Zinc dosages are substabtially reduced, to reduce the risk of Alzheimer's disease and ... 02/16/06 - 20060034896 - Serum remnant-like lipoprotein concentration regulator The present invention discloses serum remnant-like lipoprotein concentration regulators containing triglyceride of medium-chain fatty acids, wherein 90% or more by weight of the fatty acids as components of the medium-chain triglyceride are saturated fatty acids having 8 and 10 carbon atoms; weight ratio between the saturated fatty acids having 8 ... 02/16/06 - 20060034895 - Supplement food for low blood glucose recovery A supplement food which is useful when the diabetic of recuperation at home lapses into low blood glucose condition, and a supplement food for taking in easily, acting quickly to recovering low blood glucose condition, and, moreover, not having durability after recovery. A supplement food having glucose as the principal ... 02/16/06 - 20060034894 - Warming compositions and delivery systems therefor The present invention includes compositions for imparting a controlled-release warming sensation to the oral receptor areas of a user. The oral, controlled-release warming compositions include a warming agent and a hydrated or swollen food-grade polymer which forms a matrix with the warming agent. Also included are oral delivery systems for ... 02/16/06 - 20060034893 - Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation The invention relates to the use of the compound hesperidin or of one of its derivatives for the manufacture of a composition designed to stimulate bone formation and/or inhibit bone resorption in man or animals. ... 02/09/06 - 20060029643 - Food for skin moisture retention This invention relates to a food containing a glycosylated ceramide and diacylglycerol. This food is capable of improving and enhancing the barrier function of skin and increasing water holding capacity of the skin. ... 02/09/06 - 20060029642 - Methods and compositions for improved chromium complexes Complex metal-containing matrices, and especially chromium-containing matrices are produced from a water soluble preparation that is derived from an item suitable for animal (and most typically human) consumption. In particularly contemplated aspects, the water soluble preparation is an extract or filtrate of disintegrated brewer's yeast, and the so prepared complex ... 02/09/06 - 20060029641 - Calcium and magnesium nutritional supplement The present invention provides a method and composition for dietary mineral supplementation utilizing a form and dosage of calcium and magnesium for enhanced calcium absorption. The method includes the steps of delaying the absorption of the magnesium for a period of time after absorption of the calcium component of the ... 02/02/06 - 20060024352 - Phytosterol nutritional supplements The invention provides a nutritional supplement which includes phytosterol to facilitate reduction of cholesterol. The nutritional supplement may be a swallowable tablet, chewable tablet, sachet, capsule or suspension. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing ... 02/02/06 - 20060024351 - Hydrating breath freshening beverage compositions and method therefor A hydrating beverage comprises an effective amount of at least one breath freshening additive in a suitable amount of water to hydrate a person to prevent halitosis and bad breath when the hydrating beverage is consumed by the person and distributed to the mouth, the throat and the stomach of ... 01/19/06 - 20060013861 - Functional foods comprising flavonoids and tocotrienols and methods thereof Disclosed in certain embodiments is a functional food comprising an active agent combination comprising flavonoids and tocotrienols. ... 01/12/06 - 20060008509 - Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals A novel dietary supplement and nutritional aid and methods for the manufacture and administration of the same are disclosed for the efficacious treatment and/or prevention of digestive tract ulcers in horses and other animals. The dietary supplement of the present invention is effective in treating and/or preventing gastric ulcers, and ... 01/12/06 - 20060008508 - Oral pharmaceutical compositions and methods of using the same The present invention provides an edible composition for oral delivery of an active agent such as paclitaxel or a retinide. The composition comprises, in the form of a dry flowable powder: (a) an active agent such as a retinide; (b) lipid matrix composition; (c) optionally sweetener; (d) flour. Compositions of ... 01/12/06 - 20060008507 - System for generating a bioactive dosage form A system for generating a bioactive dosage form, including a first drop-on-demand fluid ejector fluidically coupled to a first reservoir that contains a first fluid having a first reactant. The first drop-on-demand fluid ejector is capable of ejecting a drop of the first fluid onto a pre-selected location of an ... 01/05/06 - 20060002984 - Diet composition and method A method of dieting includes providing a first food item; determining the caloric density and the number of calories of the first food item; providing a second food item; determining the caloric density and the number of calories of the second food item; adjusting amounts of the first and second ... 01/05/06 - 20060002983 - Muscle building preparation The present invention provides a muscle-building preparation for use during rehabilitation after injury or post-injury surgery, the preparation containing a composition comprising 42 to 55% by weight of protein, 12 to 20% by weight of fat, and 23 to 42% by weight of carbohydrate, on a dry weight basis of ... 12/22/05 - 20050281864 - High lipid diet A composition for use as a medicament, functional food or nutritional product is described which comprises at least one lipid wherein the lipid provides greater than 35% total energy of the composition. A preferred embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method ... 12/15/05 - 20050276840 - Method and system for weight management The present invention is a method for losing weight and optimizing body composition comprising the steps of eating five meals a day with 1 serving of vegetables or fruit, complex carbohydrate, and lean protein for approximately 300 calories per meal at ranges of 25-35% protein, 50-55% carbohydrate, 15-20% fat with ... 12/15/05 - 20050276839 - Appetite satiation and hydration beverage Appetite satiation and hydrating beverages and methods of delivering appetite satiation ingredients and nutrients are disclosed. According to one embodiment of the invention, the appetite satiationhydrating beverage comprises at least one complex carbohydrate, at least one chelated electrolyte, hoodia gordonii cactus, gymnema sylvestre, betaine and piperine. ... 12/15/05 - 20050276838 - Composition and method for viral inhibition A method for inhibiting Rotavirus infection by administering effective amount of lactulose is provided. Lactulose can be administered alone, in combination with other nutrient supplements such as vitamins, or as part of a nutritional product such as infant formula. ... 12/08/05 - 20050271707 - Oral compositions having increased bioavailability and methods of using the same The present invention provides an edible composition for oral delivery of an active agent such as paclitaxel or a retinide. The composition comprises, in the form of a dry flowable powder: (a) an active agent such as a retinide; (b) lipid matrix composition; (c) optionally sweetener; (d) flour. Compositions of ... 12/01/05 - 20050266049 - Method for the covering of food with polyene antifungal compositions The present invention relates to a food product (such as sausage or cheese) having a mould-like appearance which has a coating of a powder which gives a mould-like appearance, whereby the powder comprises a polyene antifungal compound. (such as natamycin). ... 11/24/05 - 20050260250 - Medicinal products incorporating bound organosulfur groups Nutraceutical and dietary supplement formulations for delivering bioavailable thiols to a host, comprising certain organosulfur radicals, such as the allyl mercapto radical, bound to larger molecules such as proteins, resulting in the formation in the host's body of various allium-related compounds such as allicin. The formulations are produced by treating ... 11/17/05 - 20050255146 - Use of metal chelates in human or animal feeding The present invention relates to the use in human and animal nutrition (monogastric and polygastric animals) of known chelates of bivalent metal Mg, Ca, Mn, Co, Cu, Zn and Fe with methionine hydroxy analogue. The present invention further relates to a method for preparing new chelates with methionine hydroxy analogue, ... 11/10/05 - 20050249782 - Drug delivery device A drug delivery device having the shape and size of a pocket card and including a drug dispersed in an edible material, is disclosed. The drug delivery device may be conveniently carried by a person, such as in the form of a cash or credit card, allowing easy access to ... 11/10/05 - 20050249781 - Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine In this application, an antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine component(s) that is characterized in that said food, feeding stuff or supplement contains lysine component(s) at such rate that 40 to 160 mg in terms of free-form lysine should be taken in per kg of body ... 11/10/05 - 20050249780 - Functional foods and process for producing functional food Functional food including milk products from which an antihypertensive effect is obtained in a more natural way, more specifically functional food of which ACE inhibitory activity is enhanced by adding EMC preferably with ACE inhibitory activity of 9,000 units or more is provided. ACE inhibitory activity of this functional food ... 11/10/05 - 20050249779 - Processed cheese products and process for producing processed cheese Processed cheeses with an antihypertensive effect greater than that of conventional cheese are provided in order to obtain a sufficient antihypertensive effect with a small intake. Specifically, processed cheeses with ACE inhibitory activity of 350 units per gram or more are manufactured using natural cheese such as cheddar cheese produced ... 10/27/05 - 20050238694 - Satiety inducing composition The invention provides the use of a whey protein and/or whey protein hydrolysate which stimulate the cellular release of the satiety peptides choleocystokinin and glucagon-like-peptide in the preparation of edible compositions. The edible compositions can be used to control body weight and have beneficial effects on satiety. Edible compositions are ... 10/27/05 - 20050238693 - Process for the preparation and activation of susbstances and a means of producing same The present invention relates to a process for the preparation and activation of a substance and a means for producing the activated substance. In particular, the invention relates to a method of treating a disease in a subject in need of such treatment, comprising the step of administering a substance ... 10/20/05 - 20050232974 - System and a method for pharmaceutical dosage preparation using jettable microemulsions A jettable solution includes an oil, the oil being one of a naturally occurring oil, an edible oil, or a removable oil, an edible surfactant, an edible aqueous solution, and a pharmaceutical solubilized into the naturally occurring oil, wherein the naturally occurring oil, the pharmaceutical, the surfactant, and the aqueous ... 10/20/05 - 20050232973 - Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles A jettable solution includes a plurality of vesicles, and a pharmaceutical payload associated with the vesicles. ... 10/13/05 - 20050226907 - Pharmanutrient composition(s) an |